• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

症状性椎动脉开口处狭窄血管内支架置入术的疗效

Outcomes of Endovascular Stenting in Symptomatic Vertebral Artery Ostial Stenosis.

作者信息

El Koussa Roy, Graft Jaime, Linder Sarah, Bansal Vibhav K

机构信息

Internal Medicine, Javon Bea Hospital, Rockford, USA.

Interventional Neurology, Javon Bea Hospital, Rockford, USA.

出版信息

Cureus. 2022 Jan 21;14(1):e21465. doi: 10.7759/cureus.21465. eCollection 2022 Jan.

DOI:10.7759/cureus.21465
PMID:35223249
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8858421/
Abstract

Vertebral artery ostial stenosis is implicated in one-fifth of all posterior circulation cerebrovascular accidents. However, uniform treatment guidelines and data on the different treatment modalities are still lacking. Endovascular stenting is an emerging therapy for symptomatic vertebral artery ostial stenosis when medical management fails. This manuscript will examine the safety and efficacy of endovascular revascularization with drug-eluting stents in a series of ten consecutive patients that had failed medical management. We also report the rate of complications and in-stent restenosis, as well as the rate of recurrent cerebrovascular accidents.

摘要

椎动脉起始部狭窄与五分之一的后循环脑血管意外有关。然而,目前仍缺乏统一的治疗指南以及关于不同治疗方式的数据。当药物治疗无效时,血管内支架置入术是一种针对有症状的椎动脉起始部狭窄的新兴治疗方法。本文将研究药物洗脱支架血管内血运重建术在连续10例药物治疗失败患者中的安全性和有效性。我们还报告了并发症和支架内再狭窄的发生率,以及复发性脑血管意外的发生率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dff/8858421/c69e70d83e27/cureus-0014-00000021465-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dff/8858421/9efe0113941b/cureus-0014-00000021465-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dff/8858421/166cc940a122/cureus-0014-00000021465-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dff/8858421/c69e70d83e27/cureus-0014-00000021465-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dff/8858421/9efe0113941b/cureus-0014-00000021465-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dff/8858421/166cc940a122/cureus-0014-00000021465-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dff/8858421/c69e70d83e27/cureus-0014-00000021465-i03.jpg

相似文献

1
Outcomes of Endovascular Stenting in Symptomatic Vertebral Artery Ostial Stenosis.症状性椎动脉开口处狭窄血管内支架置入术的疗效
Cureus. 2022 Jan 21;14(1):e21465. doi: 10.7759/cureus.21465. eCollection 2022 Jan.
2
Second Generation Drug-Eluting Stents for Endovascular Treatment of Ostial Vertebral Artery Stenosis: A Single Center Experience.第二代药物洗脱支架用于椎动脉开口处狭窄的血管内治疗:单中心经验
Front Neurol. 2019 Jul 16;10:746. doi: 10.3389/fneur.2019.00746. eCollection 2019.
3
Endovascular Treatment of Vertebral Artery Stenosis.椎动脉狭窄的血管内治疗
Prog Cardiovasc Dis. 2017 May-Jun;59(6):619-625. doi: 10.1016/j.pcad.2017.02.005. Epub 2017 Mar 8.
4
Vertebral artery stenting to prevent recurrent stroke in symptomatic vertebral artery stenosis: the VIST RCT.症状性椎动脉狭窄患者行椎动脉支架置入术预防卒中复发的 VIST RCT 研究
Health Technol Assess. 2019 Aug;23(41):1-30. doi: 10.3310/hta23410.
5
Safety and efficacy of different stent types for the endovascular therapy of extracranial vertebral artery disease.不同类型支架在颅外椎动脉疾病血管内治疗中的安全性和有效性。
Clin Res Cardiol. 2014 May;103(5):353-62. doi: 10.1007/s00392-013-0659-x. Epub 2013 Dec 28.
6
Symptomatic ostial vertebral artery stenosis treated with tubular coronary stents: clinical results and restenosis analysis.应用管状冠状动脉支架治疗有症状的椎动脉开口处狭窄:临床结果及再狭窄分析
J Endovasc Ther. 2004 Dec;11(6):719-26. doi: 10.1583/04-1336.1.
7
Advances and innovations in revascularization of extracranial vertebral artery.颅外椎动脉血运重建的进展与创新。
Neurosurgery. 2014 Feb;74 Suppl 1:S102-15. doi: 10.1227/NEU.0000000000000218.
8
Stenting versus medical treatment in patients with symptomatic vertebral artery stenosis: a randomised open-label phase 2 trial.症状性椎动脉狭窄患者的支架置入与药物治疗:一项随机开放标签 2 期试验。
Lancet Neurol. 2015 Jun;14(6):606-14. doi: 10.1016/S1474-4422(15)00017-4. Epub 2015 Apr 20.
9
Long-Term Risk of In-Stent Restenosis and Stent Fracture for Extracranial Vertebral Artery Stenting.颅外椎动脉支架置入术后支架内再狭窄和支架断裂的长期风险。
Clin Neuroradiol. 2019 Dec;29(4):701-706. doi: 10.1007/s00062-018-0708-y. Epub 2018 Jul 23.
10
Endovascular treatment of extracranial vertebral artery stenosis.颅外椎动脉狭窄的血管内治疗
World J Radiol. 2012 Sep 28;4(9):391-400. doi: 10.4329/wjr.v4.i9.391.

引用本文的文献

1
Percutaneous Transluminal Angioplasty for Atherosclerotic Stenosis of Vertebral Artery Origin.经皮腔内血管成形术治疗椎动脉起始部动脉粥样硬化狭窄
J Clin Med. 2024 Jul 9;13(14):4010. doi: 10.3390/jcm13144010.

本文引用的文献

1
Editor's Choice - Management of Atherosclerotic Carotid and Vertebral Artery Disease: 2017 Clinical Practice Guidelines of the European Society for Vascular Surgery (ESVS).编辑推荐——动脉粥样硬化性颈动脉和椎动脉疾病的管理:欧洲血管外科学会(ESVS)2017年临床实践指南
Eur J Vasc Endovasc Surg. 2018 Jan;55(1):3-81. doi: 10.1016/j.ejvs.2017.06.021. Epub 2017 Aug 26.
2
Drug eluting stents versus bare metal stents for the treatment of extracranial vertebral artery disease: a meta-analysis.药物洗脱支架与裸金属支架治疗颅外椎动脉疾病的Meta分析
J Neurointerv Surg. 2016 Aug;8(8):770-4. doi: 10.1136/neurintsurg-2015-011697. Epub 2015 Jul 15.
3
Stenting versus medical treatment in patients with symptomatic vertebral artery stenosis: a randomised open-label phase 2 trial.
症状性椎动脉狭窄患者的支架置入与药物治疗:一项随机开放标签 2 期试验。
Lancet Neurol. 2015 Jun;14(6):606-14. doi: 10.1016/S1474-4422(15)00017-4. Epub 2015 Apr 20.
4
Safety and efficacy of different stent types for the endovascular therapy of extracranial vertebral artery disease.不同类型支架在颅外椎动脉疾病血管内治疗中的安全性和有效性。
Clin Res Cardiol. 2014 May;103(5):353-62. doi: 10.1007/s00392-013-0659-x. Epub 2013 Dec 28.
5
Stroke risk after posterior circulation stroke/transient ischemic attack and its relationship to site of vertebrobasilar stenosis: pooled data analysis from prospective studies.后循环卒中和短暂性脑缺血发作后的卒中风险及其与椎基底动脉狭窄部位的关系:前瞻性研究的汇总数据分析。
Stroke. 2013 Mar;44(3):598-604. doi: 10.1161/STROKEAHA.112.669929. Epub 2013 Feb 5.
6
Multicenter study of safety in stenting for symptomatic vertebral artery origin stenosis: results from the Society of Vascular and Interventional Neurology Research Consortium.多中心研究支架置入术治疗症状性椎动脉起始部狭窄的安全性:来自血管和介入神经病学研究联合会的结果。
J Neuroimaging. 2013 Apr;23(2):170-4. doi: 10.1111/j.1552-6569.2011.00665.x. Epub 2011 Dec 30.
7
Drug-eluting stent for the treatment of symptomatic vertebral origin stenosis: Long-term results.药物洗脱支架治疗有症状的椎动脉起源狭窄:长期结果。
J Clin Neurosci. 2011 Jan;18(1):47-51. doi: 10.1016/j.jocn.2010.05.023.
8
Symptomatic ostial vertebral artery stenosis: treatment with drug-eluting stents--clinical and angiographic results at 1-year follow-up.症状性椎动脉开口处狭窄:药物洗脱支架治疗——1年随访的临床及血管造影结果
Radiology. 2009 Apr;251(1):224-32. doi: 10.1148/radiol.2511081057.
9
Vascular responses to drug eluting stents: importance of delayed healing.血管对药物洗脱支架的反应:延迟愈合的重要性。
Arterioscler Thromb Vasc Biol. 2007 Jul;27(7):1500-10. doi: 10.1161/ATVBAHA.107.144220. Epub 2007 May 17.
10
Long-term outcome after angioplasty and stenting for symptomatic vertebral artery stenosis compared with medical treatment in the Carotid And Vertebral Artery Transluminal Angioplasty Study (CAVATAS): a randomized trial.在颈动脉和椎动脉腔内血管成形术研究(CAVATAS)中,对有症状的椎动脉狭窄进行血管成形术和支架置入术与药物治疗相比的长期预后:一项随机试验。
Stroke. 2007 May;38(5):1526-30. doi: 10.1161/STROKEAHA.106.471862. Epub 2007 Mar 29.